CLRB icon

Cellectar Biosciences

14 hedge funds and large institutions have $6.87M invested in Cellectar Biosciences in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
1
Reduced
3
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AIC
1
AWM Investment Company
New York
$4.38M 2,208,368 +2,208,368 New
CAM
2
Cormorant Asset Management
Massachusetts
$1.64M 530,000
SC
3
Sophrosyne Capital
New York
$441K 142,100 -32,900 -19%
Goldman Sachs
4
Goldman Sachs
New York
$193K 62,618 +62,618 New
BA
5
Bard Associates
Illinois
$133K 43,000
VKH
6
Virtu KCG Holdings
New York
$44K 14,269 +14,269 New
Morgan Stanley
7
Morgan Stanley
New York
$29K 9,367 +6,798 +265%
Bank of America
8
Bank of America
North Carolina
$3K 905 +905 New
SSB
9
Sandy Spring Bank
Maryland
$2K 625 +625 New
SM
10
Sabby Management
Florida
$1.92K 619,632 -110,977 -15%
TRCT
11
Tower Research Capital (TRC)
New York
$1K 171 -20 -10%
AIG
12
American International Group
New York
$15 5 +5 New
Fidelity Investments
13
Fidelity Investments
Massachusetts
-98,679 Closed
KCM
14
Knoll Capital Management
Florida
-14,634 Closed
US Bancorp
15
US Bancorp
Minnesota
$0 150
Citigroup
16
Citigroup
New York
$0 66 +66 New